- Report
- April 2025
- 400 Pages
Global
From €4414EUR$5,000USD£3,818GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1324EUR$1,500USD£1,145GBP
- Report
- January 2025
- 194 Pages
Global
From €7018EUR$7,950USD£6,071GBP
- Report
- January 2025
- 160 Pages
Global
From €7018EUR$7,950USD£6,071GBP
- Report
- January 2025
- 308 Pages
Global
From €7018EUR$7,950USD£6,071GBP
- Report
- December 2024
- 102 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 119 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 67 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 159 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 143 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 198 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 87 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 69 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 180 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 73 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 49 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 70 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 68 Pages
Global
From €3487EUR$3,950USD£3,016GBP
- Report
- December 2024
- 53 Pages
Global
From €3487EUR$3,950USD£3,016GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more